Interleukin-1 receptor antagonist (IL-1ra) as a probe and as a treatment for IL-1 mediated disease
- 30 April 1992
- journal article
- review article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 14 (3) , 475-480
- https://doi.org/10.1016/0192-0561(92)90178-n
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Interleukin-1 receptor antagonist reduces mortality from endotoxin shockNature, 1990
- Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis.Journal of Clinical Investigation, 1990
- Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist.Journal of Clinical Investigation, 1990
- Circulating Interleukin-1 and Tumor Necrosis Factor in Septic Shock and Experimental Endotoxin FeverThe Journal of Infectious Diseases, 1990
- Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonistNature, 1990
- Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitorNature, 1990
- An interleukin-1 inhibitor (IL-1i) blocks IL-1 induced adhesion of neutrophils to endothelial cells:
Stephen P. Elsenberg, Robert C. Thompson, George N. Cox . Synergen, Inc., Boulder, Colorado USACytokine, 1989 - Demonstration of the effect of human interleukin-1 inhibitor (IL-1i) in cultured bovine nasal cartilage explant:
David F. Carmichael, Christopher G. Smith, and Robert C. Thompson . Synergen Inc., Boulder, Colorado USACytokine, 1989 - Human mesangial cells secrete a GBM-degrading neutral proteinase and a specific inhibitorKidney International, 1989
- Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.Journal of Clinical Investigation, 1988